Facebook Feed

2 weeks ago

Yoram Ettinger
Purim Guide for the Perplexed 2023: bit.ly/3ZdlxHY ... See MoreSee Less
View on Facebook

2 weeks ago

Yoram Ettinger
אתגר מרכזי לביטחון לאומי: bit.ly/3xkSwh1 ... See MoreSee Less
View on Facebook

2 weeks ago

Yoram Ettinger
US-sponsored anti-Israel UN Security Council statement - acumen: bit.ly/3lVqpCM ... See MoreSee Less
View on Facebook

2 weeks ago

Yoram Ettinger
bit.ly/3xHPCDc הסכמי אברהם – אינטרס ערבי, אמריקאי וישראלי: ... See MoreSee Less
View on Facebook

Global kudos to Israel’s long term viability

Irrespective of the anti-Israel BDS movements (boycott, divestment and sanctions), independent of UN condemnations, and in defiance of criticism and pressure by Western policy makers – which should not be ignored nor hyperbolized – burgeoning foreign investments in Israel, and the upgraded scope and diversity of Israel’s global trade balance, constitute a most authentic measure of Israel’s global integration/standing and global confidence in Israel’s long-term viability. Once again, complex reality triumphs over superficial conventional “wisdom.”

Some 280 global high tech giants (mostly from the US) have given kudos to Israel’s economy, in general, and Israel’s brain power, in particular, by establishing research and development (R&D) centers in the Startup Nation. Thus, Intel operates four R&D centers, Microsoft – 2, IBM – 3 R&D centers, etc..

A few scores of these high tech giants are major bio-med companies, such as Johnson & Johnson, Philips, General Electric, Abbott Laboratories, Merck Serono, Foson Pharmaceuticals and Samsung, reflecting global appreciation of Israel’s unique capabilities and contribution in the areas of medical devices, pharmaceuticals and digital and mobile healthcare. In 2014, Israel’s bio-med sector raised an all-time record of $2bn, while the acquisition of Israeli bio-med companies during 2013-14 peaked at $2.9bn. Novartis, the world’s largest pharmaceutical company, plans to expand its investments in Israel, following its 2014 investments in three Israeli companies. Johnson & Johnson, Abbott Laboratories, Medtronic and Volcano (the world’s largest intravascular imaging company) participate in the $70mn Israeli bio-med venture capital fund, Tri Ventures, and Israel’s Shavit Capital raised $75mn from US investors, mostly from the bio-med sector.

The growing global interest in Israel’s cutting edge technologies was underlined during the first quarter of 2015, when $1bn was raised by Israeli startups from – mostly – overseas investors. This was an extension of the all-time record of $1.1bn during the fourth quarter of 2014, significantly higher than the $673mn during the first quarter of 2014, $439mn – 1Q 2013 and $456mn – 1Q 2012.

Other sectors of Israel’s high tech have attracted leading investors such as Warren Buffett’s Berkshire Hathaway, which led a $22.5mn round by Israel’s eVolution Networks.  Li Ka Shing (Horizon Ventures), the wealthiest person in Asia and a veteran investor in Israel, invested $11mn in Israel’s Windward.  In 2013 he contributed $130mn to Israel’s Technion Institute of Technology. Swiss billionaire Gary Fegel invested $15mn in the Israeli biometric startup, FST.  

Rather than isolate Israel, major global companies, venture capital funds and individual investors expand their investments in Israel, aiming to enhance their global competitiveness and stay ahead of the curve. For instance, Microsoft invested in a partnership with Israel’s Akol, leveraging Akol’s dairy technologies, which have catapulted the milk productivity of Israeli cows to a world record of 12,083 kg per cow in 2014, compared to 10,097 in the US. France’s AllFlex, the global animal identification giant, acquired Israel’s milking technology company, SCR, for $250mn. The $10bn Francisco Partners – which in 2014 acquired Israel’s NSO for $120mn – recently acquired Israel’s ClickSoftware for $438mn. Canada’s Northleaf made a $175mn equity investment in Israel’s Ormat, Google acquired Israel’s Timeful, Japan’s Dentsu Aegis acquired Israel’s AbaGada for $75mn, and Intel announced a contract with Israel’s Tower Semiconductor for a few hundred million dollars.

The Israel-China trade balance and the scope of Chinese investments in Israel are galloping. Chinese tech giants – Alibaba, Baidu, Foson, Lenovo and Xiaomi – signed agreements to establish R&D centers in Israel, and in 2015, Chinese investors are expected to invest about $500mn in Israeli venture capital. Since 2012, over 30 Chinese and Hong Kong entities have become first time investors in Israel. The following cornerstones shaped the surging scope of Chinese investments in Israel and Israel-China economic and financial cooperation: the 2010 acquisition ($60mn) of Israel’s Pegasus Technologies by Yifang Digital; the 2011 acquisition of controlling interest in Israel’s $2.4bn Adama by ChemChina; the acquisition ($160mn) of TravelFusion by Ctrip.com, along with scores of Chinese investments, joint ventures and cooperation agreements during 2014; the 2014 $850mn tender to construct the new port in Ashdod; and the 2015 completion of the acquisition of controlling interest in the $2bn Tnuva by China’s BrightFood.

Bearing in mind the inherently tenuous and unpredictable nature of the Middle East, but in sharp contrast to the “Israel is isolated” theory, Israel has concluded substantial natural gas export agreements with Egypt and Jordan. And, in defiance of conventional “wisdom,” Israel-Turkey trade balance surged to $5.44bn in 2014, an 11.5% rise over 2013, and more than a 100% vault over 2009, reflecting the demand for Israel’s cutting edge commercial and defense technologies.

In 2014, notwithstanding the BDS movement in Britain, more Israeli companies are listed on the London Stock Exchange than from any other foreign country. Moreover, in 2014, Israel-Britain trade balance and Israel’s exports to Britain grew by 28% and 38% respectively.

Attesting to the enhanced global confidence in the long-term viability of Israel’s economy, and Israel’s successful integration into the global market, the chief economist of Moody’s (one of the top three global credit rating companies) said: “The performance of the Israeli economy in recent years makes Israel one of the world’s best economies… Israel’s fiscal situation is better than ever, the debt-to-GDP ratio is low and continues to fall [66% compared to 92% in the Euro Bloc, 95% and 75% in France and Germany respectively and 101% in the US], Israel’s economy has been growing for 15 straight years and there’s almost no unemployment [4.9% in May, 2015, with a record number of employed persons – 3.64mn – compared with 5.5% in the USA, 7.8% – Sweden, 10.6% – France, 12.7% – Italy and 23.2% – Spain].” According to a May 26, 2015 Bloomberg report, “Confidence in the ability of Israel to keep fiscal discipline in check has led to the biggest cut in credit risk, this quarter, among developed nations.”




Videos

The post-1967 turning point of US-Israel cooperation

Israeli benefits to the US taxpayer exceed US foreign aid to Israel

Iran - A Clear And Present Danger To The USA

Exposing the myth of the Arab demographic time bomb

Israel’s Covid-19 Economic Trends

Straight from the Jerusalem Boardroom #248
https://bit.ly/3u29k9g

Foreign investment in Israel’s high-tech companies surged to new heights in the 1st quarter of 2021 – $5.7bn in 172 deals – which is up 89% over the impressive 4th quarter of 2020 and double the volume of the 1st quarter of 2020.

2020 was the first year of surpassing $10bn in capital raised by the Israeli high-tech sector from investors in the US, Asia and Europe, who trust the maturity of Israel’s brain power. Investments in Israeli companies more than tripled in six years, reflecting the effective response by Israeli startups to the technological, medical, pharmaceutical, educational, social and digital challenges posed by Covid-19.

Israel’s economic performance in defiance of Covid-19 is presented by Dr. Adam Reuter, the Chairman and Founder of “Financial Immunities,” Israel’s largest financial-risk management firm, and the co-author of Israel – Island of Success:

  1. Israel has led the globe in the rapid administration of Covid-19 vaccinations due to effective negotiations with Pfizer and an efficient, country-wide medical infrastructure.
  2. Israel is the second lowest among OECD countries in the number of Covid-19 deaths per number of Covid-19 cases: 0.7% compared to the 2.3% OECD average. Israel features a young population (median age of 30 compared to the OECD’s 42) and an effective country-wide medical infrastructure, including top level HMOs and hospitals.
  3. Israel is ranked 12th from the bottom among the 37 OECD countries in the number of deaths per million inhabitants: 645 compared to 1,145 OECD average.
  4. The International Monetary Fund’s 2025 GDP growth forecast for OECD countries: Israel – 4%, OECD average – 2.2%, US – 1.8%, Australia – 2.5%, Ireland – 2.6%, France and Canada – 1.7%, the UK – 1.6%, Germany – 1.2%, etc.
  5. Israel’s 2020 GDP was reduced by 2.5%, compared to the OECD average reduction of 4.1%, South Korea – 1%, Norway – 0.8%, Australia – 2.6%, US – 3.5%, Japan – 4.8%, Germany – 5%, France – 8%, the UK – 10% reduction, etc. GDP growth was recorded in New Zealand – 2.4% and Ireland – 3.5%.
  6. In 2020, Israel was ranked 20th among the 37 members of the OECD in terms of GDP per capita, featuring $43,000 (GDP – $408bn), ahead of Japan, Italy and Spain, and very close behind the UK ($44,000) and France ($45,000).
  7. Israel’s debt-to-GDP ratio increased from 60% in 2019 to 72% in 2020, compared to the OECD’s average increase from 66% to 82%. The 2020’s debt-to-GDP ratio was 266% in Japan, Italy – 161%, the US – 131%, Germany – 73%, etc.
  8. Israel’s foreign exchange reserves-to-GDP ratio of 41% (3rd among the OECD countries) attests to its financial stability, and Israel’s capability to raise foreign credit promptly in a cost-effective manner. Israel’s foreign exchange reserves in March 2021 – $186bn.
  9. During the past decade, Standard and Poor (S&P) accorded Israel a positive credit rating trend, unlike the negative trend for the G-7 countries. In 2020, notwithstanding Covid-19, Israel’s credit rating (S&P) remained at AA.
  10. Some 380 global high-tech giants operate in Israel, including Microsoft, Amazon, IBM, Intel, Cisco, Apple, Verizon, Applied Materials, Dell, HP, Kodak, Oracle, Philips, SAP, Medtronics, GM, eBay, GE, etc. Israel leads the world in the ratio of research and development investment to GDP: 4.9%. 85% of this investment comes from the business sector.

 




Videos

The post-1967 turning point of US-Israel cooperation

Israeli benefits to the US taxpayer exceed US foreign aid to Israel

Iran - A Clear And Present Danger To The USA

Exposing the myth of the Arab demographic time bomb